Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium
- PMID: 7515561
- PMCID: PMC1887457
Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium
Abstract
Activation of the complement (C) system has been documented in both experimental and clinical studies of myocardial infarction, but the exact time course and mechanisms leading to C activation have remained unclear. Our earlier postmortem study on human beings showed that formation of the membrane attack complex (MAC) of C was associated with loss of CD59 (protectin), an important sarcolemmal regulator of MAC, from the infarcted area. The recent discovery of a rat analogue of CD59 has now allowed the first experimental evaluation of the temporal and spatial relationship between C component deposition and loss of CD59 in acute myocardial infarction (AMI). After ligating the left coronary artery in rats the earliest sign of C activation, focal deposition of C3, was observed at 2 hours. Deposition of the early (C1, C3) and late pathway (C8, C9) components in the AMI lesions occurred at 3 hours. Glycophosphoinositol-anchored rat CD59 was expressed in the sarcolemmal membranes of normal cardiomyocytes. In Western blot analysis extracts of normal rat heart CD59 appeared as a band of 21 kd of molecular weight under nonreducing conditions. Loss of CD59 in the AMI lesions was observed in association with deposits of MAC from day one onward. Our results show that C activation universally accompanies AMI in vivo. It is initiated within 2 hours after coronary artery obstruction via deposition of C3, which may be due to generation of the alternative pathway C3 convertase in the ischemic area. Deposition of C1 and late C components also starts during the early hours (2 to 4 hours) after ischemia. Subsequent loss of the protective CD59 antigen may initiate postinjury clearance of the irreversibly damaged tissue.
Similar articles
-
Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.Lab Invest. 1992 Nov;67(5):608-16. Lab Invest. 1992. PMID: 1279272
-
Role of CD59 in experimental glomerulonephritis in rats.Kidney Int. 1994 Jul;46(1):191-200. doi: 10.1038/ki.1994.259. Kidney Int. 1994. PMID: 7523753
-
Regulation of complement membrane attack complex formation in myocardial infarction.Am J Pathol. 1993 Jul;143(1):65-75. Am J Pathol. 1993. PMID: 7686345 Free PMC article.
-
Membrane defence against complement lysis: the structure and biological properties of CD59.Immunol Res. 1993;12(3):258-75. doi: 10.1007/BF02918257. Immunol Res. 1993. PMID: 7507156 Review.
-
The possible role of membrane complement regulators in vasculitis.Behring Inst Mitt. 1993 Aug;(92):184-90. Behring Inst Mitt. 1993. PMID: 7504449 Review.
Cited by
-
Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure.Comp Funct Genomics. 2003;4(6):571-83. doi: 10.1002/cfg.347. Comp Funct Genomics. 2003. PMID: 18629021 Free PMC article.
-
Early markers for myocardial ischemia and sudden cardiac death.Int J Legal Med. 2016 Sep;130(5):1265-80. doi: 10.1007/s00414-016-1401-9. Epub 2016 Jul 8. Int J Legal Med. 2016. PMID: 27392959
-
Complement C3 Reduces Apoptosis via Interaction with the Intrinsic Apoptotic Pathway.Cells. 2023 Sep 15;12(18):2282. doi: 10.3390/cells12182282. Cells. 2023. PMID: 37759504 Free PMC article.
-
Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.Circulation. 2018 Oct 16;138(16):1720-1735. doi: 10.1161/CIRCULATIONAHA.118.034600. Circulation. 2018. PMID: 29802205 Free PMC article.
-
Growth factor therapy for cardiac repair: an overview of recent advances and future directions.Biophys Rev. 2020 Aug;12(4):805-815. doi: 10.1007/s12551-020-00734-0. Epub 2020 Jul 20. Biophys Rev. 2020. PMID: 32691300 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous